Working with leading TTOs and Enterprises, ADLIB provides talent to support the complete technology transfer cycle from market analysis, IP protection, sales/marketing, funding, and long-term business planning. 

All aspects of Life Sciences are covered for spin-out formation, start-ups and licensing across clinical outcomes, translational research, therapeutics, MedTech, medical devices, vaccines, and synthetic biology. 

We partner with leading TTOs and Enterprises, to enable them to provide commercialisation expertise for the ever-increasing demand in areas such as Quantum Engineering & Computing, Renewable Technologies, Physics, Chemistry, Materials Science and Deep Tech. 

With the modern era of Robotics, Quantum Computing and Ai, we help provide commercialisation experts who guide Deep Tech scientists and engineers through the technology transfer cycle. 

ADLIB provides experts with experience of patient-oriented research including human disease, clinical trials, therapeutic interventions, and new technology development. 

Over recent times there has been an increase in new spin-outs and start-ups with the aim to have a positive social, environmental, or cultural impact. ADLIB is able to source experts with a record of accomplishment in helping the planet and humanity. 

With increasingly less risk appetite from investors, it is crucial to have experienced professionals in business development, investment strategies and grant applications to ensure start-ups and spin-outs can get off the ground financially. ADLIB have placed extensively in these areas for TTO’s, Enterprise and start-ups. 

ADLIB has a proven track record in growing Licensing teams for world leading TTO’s. These teams aid innovation ownership and control of IP, which enables royalty incomes for scientists, engineers, and industry partners.